351 related articles for article (PubMed ID: 31293595)
1. Fine-Tuning of Type I Interferon Response by STAT3.
Tsai MH; Pai LM; Lee CK
Front Immunol; 2019; 10():1448. PubMed ID: 31293595
[TBL] [Abstract][Full Text] [Related]
2. STAT3 Cooperates With Phospholipid Scramblase 2 to Suppress Type I Interferon Response.
Tsai MH; Lee CK
Front Immunol; 2018; 9():1886. PubMed ID: 30158934
[TBL] [Abstract][Full Text] [Related]
3. The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.
Blaszczyk K; Nowicka H; Kostyrko K; Antonczyk A; Wesoly J; Bluyssen HA
Cytokine Growth Factor Rev; 2016 Jun; 29():71-81. PubMed ID: 27053489
[TBL] [Abstract][Full Text] [Related]
4. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2.
Icardi L; Lievens S; Mori R; Piessevaux J; De Cauwer L; De Bosscher K; Tavernier J
FASEB J; 2012 Jan; 26(1):240-9. PubMed ID: 21957129
[TBL] [Abstract][Full Text] [Related]
5. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
[TBL] [Abstract][Full Text] [Related]
6. STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.
Blaszczyk K; Olejnik A; Nowicka H; Ozgyin L; Chen YL; Chmielewski S; Kostyrko K; Wesoly J; Balint BL; Lee CK; Bluyssen HA
Biochem J; 2015 Mar; 466(3):511-24. PubMed ID: 25564224
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.
Urin V; Shemesh M; Schreiber G
J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of Tetraodon nigroviridis Mx gene promoter activity by constitutively-active forms of STAT1, STAT2, and IRF9.
Cheng CH; Chou CM; Chu CY; Chen GD; Lien HW; Hwang PP; Chang MS; Huang CJ
Fish Shellfish Immunol; 2014 May; 38(1):230-43. PubMed ID: 24680831
[TBL] [Abstract][Full Text] [Related]
9. Porcine Reproductive and Respiratory Syndrome Virus nsp11 Antagonizes Type I Interferon Signaling by Targeting IRF9.
Wang D; Chen J; Yu C; Zhu X; Xu S; Fang L; Xiao S
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092569
[TBL] [Abstract][Full Text] [Related]
10. MiR-103/miR-107 inhibits enterovirus 71 replication and facilitates type I interferon response by regulating SOCS3/STAT3 pathway.
Huang B; Chen H; Zheng Y
Biotechnol Lett; 2021 Jul; 43(7):1357-1369. PubMed ID: 33796959
[TBL] [Abstract][Full Text] [Related]
11. A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.
Kraus TA; Lau JF; Parisien JP; Horvath CM
J Biol Chem; 2003 Apr; 278(15):13033-8. PubMed ID: 12574168
[TBL] [Abstract][Full Text] [Related]
12. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.
Hofer MJ; Li W; Lim SL; Campbell IL
J Neurosci; 2010 Jan; 30(3):1149-57. PubMed ID: 20089923
[TBL] [Abstract][Full Text] [Related]
13. ISGF3 and STAT2/IRF9 Control Basal and IFN-Induced Transcription through Genome-Wide Binding of Phosphorylated and Unphosphorylated Complexes to Common ISRE-Containing ISGs.
Nowicka H; Sekrecka A; Blaszczyk K; Kluzek K; Chang CY; Wesoly J; Lee CK; Bluyssen HAR
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139463
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond.
Suprunenko T; Hofer MJ
Cytokine Growth Factor Rev; 2016 Jun; 29():35-43. PubMed ID: 26987614
[TBL] [Abstract][Full Text] [Related]
15. IRF9 and unphosphorylated STAT2 cooperate with NF-κB to drive IL6 expression.
Nan J; Wang Y; Yang J; Stark GR
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3906-3911. PubMed ID: 29581268
[TBL] [Abstract][Full Text] [Related]
16. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
17. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency.
Gothe F; Stremenova Spegarova J; Hatton CF; Griffin H; Sargent T; Cowley SA; James W; Roppelt A; Shcherbina A; Hauck F; Reyburn HT; Duncan CJA; Hambleton S
J Allergy Clin Immunol; 2022 Oct; 150(4):955-964.e16. PubMed ID: 35182547
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function.
Rengachari S; Groiss S; Devos JM; Caron E; Grandvaux N; Panne D
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E601-E609. PubMed ID: 29317535
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs.
Wong LH; Hatzinisiriou I; Devenish RJ; Ralph SJ
J Immunol; 1998 Jun; 160(11):5475-84. PubMed ID: 9605150
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
